High risk groups 1–3
- People exposed to occupational and environmental dusts, chemicals and airborne hazards
- Aboriginal and Torres Strait Islander people and those from culturally and
linguistically diverse backgrounds - Smokers and ex-smokers of tobacco and e-cigarette products
Considerations in pregnancy
- Pregnant women with airway disease should be seen by a specialist
Urgent referral
- For acute respiratory exacerbations refer to the Primary Clinical Care Manual
1. What is chronic obstructive pulmonary disease (COPD)? 1–3
- A lung condition characterised by chronic respiratory symptoms (dyspnoea, cough, sputum production) due to abnormalities of the airways (bronchitis, bronchiolitis, emphysema) that cause persistent and progressive airflow obstruction
- The primary contributing factor is exposure to tobacco smoke. See Smoking cessation
- All comorbid chronic conditions increase the risk of poor lung function and death
2. Diagnosis of COPD 1–3
- A diagnosis should be considered in any patient who has:
- a history of recurrent lower respiratory tract infections
- exposure to tobacco smoke or occupational or environmental dusts, vapours, fumes and gases
- breathlessness that is persistent, progresses over time and worsens with exercise
- chronic cough and sputum production +/- recurrent chest infections
- forced expiratory post-bronchodilator FEV1/FVC ratio < 0.70 (airflow limitation)
- Some people present with worsening breathlessness, a cough +/- sputum production or limitation to activity
- Identifying the airflow limitation and symptoms helps to classify COPD severity. See Table 1. to determine:
- its impact on patient health
- the risk of future exacerbations, hospital presentations or death
- management and treatment
Table 1. Classification of COPD according to airflow obstruction1,2 | |||
---|---|---|---|
Stages | Mild | Moderate | Severe |
Symptoms |
|
|
|
Lung Function | FEV1 ≈ 60-80% predicted | FEV1 ≈ 40-59% predicted | FEV1 < 40% predicted |
3. Management of COPD 1,2
- Management goals are to:
- reduce symptoms to improve exercise tolerance and health status
- reduce risk of exacerbations to prevent disease progression and mortality
- encourage those who smoke to stop. See Smoking cessation
- identifying and addressing comorbidities, in particular:
- any respiratory conditions including Asthma (adults and children > 12) and Bronchiectasis, any cardiac conditions including Heart failure, Hypertension, and Rheumatic heart disease
- Diabetes
- Osteoporosis
- Support patient self-management 1–3
- Support the patient with lifestyle modification with particular attention to
Smoking cessation and pulmonary rehabilitation. See 3.13 Pulmonary rehabilitation program - Provide COPD education (Resource 1.) and discuss:
- airway clearance and breathing techniques. See Resource 2.
- medicine usage, effects and compliance
- develop a COPD action plan. See below
- Refer patient to SMoCC, a phone service that supports patients manage their condition. See Resource 3.
- Encourage the patient to identify barriers to adequate lifestyle modification and
medical adherence and create goals to overcome those barriers. See Engaging our patients
- Support the patient with lifestyle modification with particular attention to
- Social-emotional support 2,3
- See Social-emotional wellbeing
- Action plan 1–3
- Develop an action plan (Resource 4.) with the patient so they can:
- recognise and monitor exacerbations and severity. See Table 1.
- intervene early to prevent exacerbations
- understand and feel comfortable using it
- Review and update action plan each visit, especially when changing medicines
- Develop an action plan (Resource 4.) with the patient so they can:
- Minimising occupational exposure 1–3
- Discuss minimising exposure to occupational (particularly mining and quarry workers) risk factors including:
- smoke, gases, vapours and fumes
- biological and mineral dusts
- diesel exhaust
- indoor and outdoor pollutants and chemicals
- Discuss minimising exposure to occupational (particularly mining and quarry workers) risk factors including:
- Monitor health status 1–3
- According to 5. Cycle of care, regularly monitor:
- temperature, pulse, respiratory rate, blood pressure, pulse oximetry
- weight and BMI
- sputum colour and amount
- lung function by spirometry before and 10–15 minutes after 4 puffs of salbutamol via a spacer. See Resources 5.
- ECG for Coronary heart disease changes and right ventricular strain pattern
- chest x-ray for Bronchiectasis, emphysema, lung hyperinflation, heart failure
- echocardiogram for pulmonary hypertension
- swallowing difficulties. Refer to speech pathologist
- Use the COPD Assessment Test (CAT) to measure the impact of COPD on the patient and changes over time. See Resource 6.
- According to 5. Cycle of care, regularly monitor:
- Smoking cessation 1–3
- Quitting smoking is the most effective means to prevent COPD from progressing
- Perform spirometry on past or present smokers with recurrent respiratory infections or frequent and unusual sputum production. See Resource 5. and 7.
- See Smoking cessation
- Improve exercise tolerance 1–3
- Encourage patient to keep as active as possible to maintain lung function
- Refer to a pulmonary rehabilitation program. See 3.12 Pulmonary rehabilitation program
- See Physical activity and sleep
- Nutrition 1–3
- Lung disease increases the risk of poor nutrition, weight loss and reduced muscle and bone strength due to:
- increased energy needs
- changes in appetite
- lack of energy to shop, cook or eat meals
- an increased need for essential vitamins, minerals and antioxidants
- Refer to dietitian if there is weight loss or weight gain
- For unintended weight loss, refer to exclude an alternate diagnosis e.g. cancer, diabetes
- See Diet and nutrition
- Lung disease increases the risk of poor nutrition, weight loss and reduced muscle and bone strength due to:
- Sleep hygiene 1–3
- Medicines, breathing difficulties, anxiety and depression in COPD can disrupt sleep
- Patients with COPD and OSA have:
- a higher prevalence of pulmonary hypertension than those without OSA
- improved survival outcomes and lower rates of hospital admission with CPAP use
- Assess a patient’s daytime sleepiness and OSA risk by using a validated tool. If they score highly refer to a sleep specialist. See Resource 8.
- Prevent respiratory infections 1–4
- Respiratory illnesses contribute to COPD exacerbations and progression
- Provide Influenza, pneumococcal, pertussis and COVID-19 vaccines as per the Australian Immunisation Handbook
- Home oxygen 1–3
- Long term oxygen therapy (18 hours/day) reduces cardiac workload and prolongs survival in patients who have chronic resting arterial hypoxemia:
- FEV1 < 40% predicted
- SpO2 < 88%
- those with pulmonary hypertension
- PaO2 ≤ 55 mmHg or SpO2 ≤ 88%
- PaO2 55–59 mmHg or SpO2 with evidence of right heart failure, pulmonary hypertension or high red cell count
- Home O2 is evaluated by blood gases after 4–8 weeks when the person is stable, to ascertain effectiveness and whether to continue
- Medical Aids Subsidy Scheme (MASS) can supply home oxygen to eligible patients. See Resource 9.
- Provide a home visit for oxygen concentrator education
- Long term oxygen therapy (18 hours/day) reduces cardiac workload and prolongs survival in patients who have chronic resting arterial hypoxemia:
- Prevention of complications 1
- Identify risk factors for Osteoporosis by assessing:
- vitamin D levels
- mobilisation
- use of high dose corticosteroids
- underlying decreased bone mineral density
- bone densitometry where appropriate
- Assess Australian cardiovascular disease risk calculator
- Pulmonary hypertension:
- is difficult to treat
- manifests late due to poor lung ventilation from ongoing exacerbations
- management relies on smoking cessation, improving diet and physical activity and medicine adherence to prevent right heart failure
- Identify risk factors for Osteoporosis by assessing:
- Pulmonary rehabilitation program 2
- Offered to all symptomatic patients with more than 2 exacerbations per year or with moderate to severe COPD to avoid hospitalisation
- Refer to the Pulmonary Rehabilitation Toolkit. See Resource 10.
- Refer to an exercise physiologist or the Lung Foundation for rehabilitation program details and/or training. See Resource 11.
- Airway clearance technique
- An early intervention strategy to clear lung secretions and avoid hospitalisation:
- start with 5 deep abdominal breaths. Expand chest fully, starting with the
diaphragm and lower ribs. Avoid lifting or shrugging shoulders - do 30–60 seconds of relaxed breathing. Breathe from the diaphragm. With a hand feel the stomach rising and falling. Shoulders should be relaxed
- do another 5 deep abdominal breaths
- follow this with 30–60 seconds of relaxed breathing
- take a medium sized breath in and huff the air out a little more forcefully
- start with 3 cycles of gentle huffs. Finish with 2 cycles of more forceful huffs
- finish with a cough to clear any secretions left in the main airways
- repeat the cycle 2–3 times or until no more secretions can be removed
- start with 5 deep abdominal breaths. Expand chest fully, starting with the
- Refer to a physiotherapist if patient is unable to clear lung secretions
- For airway clearance information see Resource 2.
- An early intervention strategy to clear lung secretions and avoid hospitalisation:
- Falls prevention
- Screen for individual falls risk. See Resource 12.
- Refer to a balance and strength group by a physiotherapist or exercise physiologist
- Refer to an occupational therapist to assess for home modification requirements to minimise trip and fall hazards
- Palliative support 1–3
- Consider discussing a palliative approach to care, advance care planning, and end-of-life issues when patient has:
- predicted FEV1 < 25%
- dependence on oxygen
- respiratory or heart failure or other comorbidities
- weight loss or muscle wasting
- decreased functional status with increased dependence on others
- advanced age
- See Palliative care and Advance Care Planning
- Refer to physiotherapist or occupational therapist for a home support assessment e.g. wheel chair, bedding, rails etc
- Refer eligible patients to Home and Community Care (HACC) and MASS services. See Resource 9.
- Consider discussing a palliative approach to care, advance care planning, and end-of-life issues when patient has:
Table 1. Stepwise management of stable COPD 1–3,6
4. Medicines for COPD
- Monitor medicine adherence and correct inhaler technique according to product instructions. See Resource 13.
- See Table 1. for a guide to manage stable COPD
Table 2. Medicines for all stages of COPD (continued) 1–3,6 |
---|
SABA
|
|
SAMA
|
|
LAMA (Non-LAM)
|
|
LABA |
|
Combination ICS/LABA*
|
|
Oxygen therapy*
|
Oral corticosteroids
|
Antibiotics
|
|
Symptom relief |
|
*See LAM and PBS for medicine indications and restrictions |
5. Cycle of care
Cycle of care summary for COPD | ||||
---|---|---|---|---|
COPD severity | Mild | Moderate | Severe | |
Action | Dx | Review frequency | ||
Height | ||||
Blood pressure | - | 12 mthly | 6 mthly | |
Weight | - | 12 mthly | 6 mthly | |
BMI | - | 12 mthly | 6 mthly | |
Pulse rate | - | 12 mthly | 6 mthly | |
Respiratory rate | - | 12 mthly | 6 mthly | |
Temperature | - | 12 mthly | 6 mthly | |
Spirometry | - | 12 mthly | 6 mthly | |
SpO2 | - | 12 mthly | 6 mthly | |
PaO2 | For those on or being considered for home oxygen | |||
CAT score | - | 12 mthly | 6 mthly | |
Lifestyle modifications education | Every visit. Specifically smoking cessation, physical activity and diet and nutrition | |||
Social-emotional wellbeing | - | 12 mthly | 6 mthly | |
Advance care planning | - | 12 mthly | 6 mthly | |
End of life care | - | - | 6 mthly | |
Inhaler puffer technique | Every visit | |||
COPD action plan | Every visit | |||
Influenza, pneumococcal, pertussis and COVID-19 vaccines | See the Australian Immunisation Handbook for schedule | |||
ECG | 2 yrly | 2 yrly | 12 mthly | |
Chest x-ray | - | If frequent infective exacerbations | ||
Self-monitoring | - | 12 mthly | 6 mthly | |
HW/RN review | - | 6 mthly | 2 mthly | |
MO/NP review | - | 12 mthly | 6 mthly | |
Medicine review | - | 12 mthly | 12 mthly | |
Pulmonary rehabilitation | - | Attend | Attend | |
Physiotherapist | - | 12 mthly | 12 mthly | |
Specialist review | - | If frequent infective exacerbations |
6. References
- All Chronic Conditions Manual references are available via the downloadable References PDF
7. Resources
- Better living with Chronic Obstructive Pulmonary Disease A Patient Guide and The Lung Foundation resources
- Airway clearance resource
- Self-Management of Chronic Conditions (SMoCC) service
- Lung foundation COPD action plan or for Aboriginal or Torres Strait Islander people
- The spirometry handbook and training tools and the COPD and spirometry resources
- The COPD Assessment Test (CAT)
- COPD screening using spirometry
- The Epworth Sleepiness Scale and STOP-Bang questionnaire
- Access the Medical Aids Subsidy Scheme (MASS) and Queensland Community Support Scheme
- The Australian Lung Foundation Pulmonary Rehabilitation Toolkit
- The Lung Foundation training and education website
- Individual falls risk screening and Queensland Government’s Stay on Your Feet Toolkit
- Lung Foundation inhaler use videos and printable instructions and the National Asthma Council